Zebra Capital Management’s Idexx Laboratories IDXX Stock Holding History

Zebra Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,456	Closed	-$401K	–	332
2019 Q2	$401K	Sell	1,456 -362	-20%	-$89.2K	0.21%	150
2019 Q1	$407K	Sell	1,818 -586	-24%	-$121K	0.22%	148
2018 Q4	$447K	Sell	2,404 -197	-8%	-$40.4K	0.28%	142
2018 Q3	$649K	Sell	2,601 -2,311	-47%	-$561K	0.3%	104
2018 Q2	$1.07M	Sell	4,912 -2,558	-34%	-$527K	0.46%	41
2018 Q1	$1.43M	Buy	7,470 +4,293	+135%	+$792K	0.51%	34
2017 Q4	$497K	Buy	+3,177	New	+$500K	0.17%	260
2015 Q4	–	Sell	-9,806	Closed	-$728K	–	239
2015 Q3	$728K	Hold	9,806	–	–	0.45%	83
2015 Q2	$629K	Sell	9,806 -1,786	-15%	-$124K	0.37%	132
2015 Q1	$895K	Buy	+11,592	New	+$902K	0.46%	99

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Zebra Capital Management's IDXX Position: Q3 2019 in Review

Zebra Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2019, closing a stake of 1,456 shares — an estimated $401K sold.

Zebra Capital Management first reported a position in IDXX in Q1 2015 and held it in 10 quarters. The position peaked at $1.43M in Q1 2018. 720 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

Zebra Capital Management reported no remaining Idexx Laboratories position as of Q3 2019 after selling out during the quarter.
Zebra Capital Management sold 1,456 Idexx Laboratories shares in Q3 2019, an estimated $401K.
Zebra Capital Management first reported a position in Idexx Laboratories in Q1 2015 and held it in 10 quarters.
Zebra Capital Management's Idexx Laboratories position peaked at $1.43M in Q1 2018.
720 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on Zebra Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.